Won Kee Lee
- Cancer Research top 2%
- MicroRNA in disease regulation 10
- Oncology top 5%
- Lung Cancer Research Studies 12
- Molecular Biology top 5%
- RNA modifications and cancer 27
- Epigenetics and DNA Methylation 22
- DNA Repair Mechanisms 10
- Cell death mechanisms and regulation 9
- Hepatology top 5%
-
- Lung Cancer Treatments and Mutations 20
-
- Liver Disease Diagnosis and Treatment 12
- Co-authors
- Jae Yong ParkChang Ho KimJin Eun ChoiSin KamTae Hoon JungSung IckJin Sung JangYoung Mo Kang
- Journals
- Lung Cancer (8 papers)Scientific Reports (7 papers)Journal of Korean Medical Science (7 papers)
- Partner nations
- South KoreaSudanUnited States
In The Last Decade
Won Kee Lee
190 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 147
- Cancer Research 698
- Oncology 681
- Molecular Biology 1.5k
- Pathology and Forensic Medicine 287
- Hepatology 125
Countries citing papers authored by Won Kee Lee
This map shows the geographic impact of Won Kee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Kee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Kee Lee more than expected).
Fields of papers citing papers by Won Kee Lee
This network shows the impact of papers produced by Won Kee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Kee Lee. The network helps show where Won Kee Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Won Kee Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 35 | |
| 14 | 2019 | 12 | |
| 15 | 2019 | 6 | |
| 16 | 2016 | 7 | |
| 17 | 2016 | 1 | |
| 18 | 2013 | 14 | |
| 19 | 2009 | 53 | |
| 20 | 2008 | 20 |
About Won Kee Lee
Won Kee Lee is a scholar working on Leadership and Management, Cancer Research, Oncology, Hepatology and Emergency Medical Services, having authored 198 papers that have together received 3.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (27 papers), Epigenetics and DNA Methylation (22 papers), Lung Cancer Treatments and Mutations (20 papers), Liver Disease Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (12 papers), MicroRNA in disease regulation (10 papers), DNA Repair Mechanisms (10 papers) and Cell death mechanisms and regulation (9 papers). The work is most often cited by research in Cancer Research (698 citations), Oncology (681 citations), Molecular Biology (1.5k citations), Pathology and Forensic Medicine (287 citations) and Hepatology (125 citations). Won Kee Lee has collaborated with scholars based in South Korea, Sudan and United States. Frequent co-authors include Jae Yong Park, Chang Ho Kim, Jin Eun Choi, Sin Kam, Tae Hoon Jung, Sung Ick, Jin Sung Jang, Young Mo Kang, Dong Sun Kim and Yi Young Choi. Their work appears in journals such as Lung Cancer, Scientific Reports, Journal of Korean Medical Science, Cancer Epidemiology Biomarkers & Prevention and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.